You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 7, July 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ophthalmological Disorders, Other
 •Pulmonary Diseases
 •Pulmonary Diseases, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ocular Pathologic Features of Hermansky-Pudlak Syndrome Type 1 in an Adult

Min Zhou, MD; Libe Gradstein, MD; John A. Gonzales; Ekaterini T. Tsilou, MD; William A. Gahl, MD, PhD; Chi-Chao Chan, MD

Arch Ophthalmol. 2006;124:1048-1051.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disease, characterized by a triad of oculocutaneous albinism (OCA), bleeding diathesis due to deficiency of dense bodies in platelets, and lysosomal accumulation of ceroid lipofuscin.1 Seven genetic subtypes of HPS have been identified in humans2; HPS1 on chromosome 10q23 is the most common and represents a founder effect in northwest Puerto Rico.1 The clinical features of HPS and its ophthalmic involvement3-4 are well documented, but no ocular histopathology has been published (to our knowledge). Herein, we describe the ocular histopathology of an adult patient with HPS type 1 (HPS-1).

Report of a Case

This study was approved by the National Human Genome Research Institute and National Eye Institute institutional review boards for human subjects, and informed consent was obtained from the patient. A 43-year-old . . . [Full Text of this Article]


Pathologic Findings

Comment

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Abnormal Foveal Morphology in Ocular Albinism Imaged With Spectral-Domain Optical Coherence Tomography
Chong et al.
Arch Ophthalmol 2009;127:37-44.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.